Spatial Designs on Metamaterial Sensors for Enhancing Signals and Detecting Extracellular Vesicles
Source abstract
Abstract
High Resolution Image Download MS PowerPoint Slide Biosensors, while holding immense promise for biomarker detection, face substantial challenges in analytical performance, fabrication intricacies, and complex applications, hindering their seamless integration into point-of-care (POC) settings. Metamaterial-based plasmonic biosensors offer tremendous potential for biomarker detection; however, their widespread adoption in POC diagnostics remains hampered by limitations in sensitivity, fabrication complexity, and production cost. Herein, we introduce, for the first time, in situ-controlled spatial designs on metamaterial-based plasmonic sensors, demonstrating unprecedented sensitivity in detecting extracellular vesicles (EVs). In the fabrication process, commercially available optical disks were repurposed as nanostructured substrates, yielding a cost reduction of up to 260-fold ($0.90 per sensor) and a fabrication time reduction of approximately 960-fold, compared to conventional e-beam lithography. Leveraging inherent nanogratings, measurements are conducted on a compact, palm-sized platform, addressing challenges in usability and portability associated with bulky optical designs. Through ex situ immobilization of gold nanoparticles (AuNPs) or in situ formation of nanoislands (NIs), we have engineered plasmonic hotspots that substantially enhanced local electric field intensities, thereby amplifying the bulk refractive index sensitivity of the sensors. Finite-difference time-domain simulations confirmed that the spatial arrangement and interparticle distances of spatial designs enhance near-field effects. The optimized platform exhibits up to a 5.5-fold enhancement in refractive index sensitivity. Moreover, based on data obtained from nanoparticle tracking analysis (NTA), fluorescence-enhanced NTA (fNTA), and recent literature benchmarks, the platform demonstrated detection limits of 10 4 particles/μL (as determined by raw NTA measurements), approximately 330 fg/μL (estimated via literature-based EV mass calculations), and 138 EVs/μL (quantified via fNTA using marker-specific labeling). Herein, we anticipate that repurposing disks as metamaterial sensors has the potential to address pressing challenges in usability, portability, cost, and complexity. Besides, 3D configurations on sensors would improve the analytical performance, offering highly sensitive and facile platforms for diverse applications in the future.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Extracellular vesicles in disease · Advanced biosensing and bioanalysis techniques · Plasmonic and Surface Plasmon Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
UNAM − National Nanotechnology Research Center
Bilkent University
Institute of Materials Science and Nanotechnology
Sabanci University Nanotechnology and Application Center (SUNUM)
Sabanci University
School of Civil Aviation
Firat University
Funding
Bilim Akademisi · T?rkiye Bilimsel ve Teknolojik Arastirma Kurumu · Izmir Biyotip ve Genom Merkezi, Dokuz Eyl?l ?niversitesi · T?rkiye Saglik Enstit?leri Baskanligi · T?rkiye Bilimler Akademisi
References (66)
Show source-provided references
1. 10.1088/1361-6528/ac43e910.1088/1361-6528/ac43e9 ↗
2. 10.1021/nn303623210.1021/nn3036232 ↗
3. 10.1007/s42247-020-00150-w10.1007/s42247-020-00150-w ↗
4. 10.1021/cr400062310.1021/cr4000623 ↗
5. 10.3390/biomimetics502002010.3390/biomimetics5020020 ↗
6. 10.3390/s8031400010.3390/s80314000 ↗
7. 10.1038/nnano.2011.4410.1038/nnano.2011.44 ↗
8. 10.1039/C9AN01998G10.1039/C9AN01998G ↗
9. 10.1021/nl103025u10.1021/nl103025u ↗
10. 10.1021/ac901716d10.1021/ac901716d ↗
11. 10.1039/c3an36828a10.1039/c3an36828a ↗
12. 10.1002/9783527830343.ch110.1002/9783527830343.ch1 ↗
13. Chohan J. S. · 2022 · 1
14. 10.1002/adma.20190716010.1002/adma.201907160 ↗
15. 10.1515/nanoph-2017-013010.1515/nanoph-2017-0130 ↗
16. 10.1117/12.250862410.1117/12.2508624 ↗
17. 10.1016/j.spmi.2019.05.00610.1016/j.spmi.2019.05.006 ↗
18. 10.1016/j.bios.2018.11.00510.1016/j.bios.2018.11.005 ↗
19. 10.1016/j.sna.2021.11285810.1016/j.sna.2021.112858 ↗
20. 10.3390/s2203090310.3390/s22030903 ↗
21. 10.1039/C9AN00701F10.1039/C9AN00701F ↗
22. 10.1038/s41598-019-44396-910.1038/s41598-019-44396-9 ↗
23. 10.1039/C8NR10539A10.1039/C8NR10539A ↗
24. 10.1038/srep1479010.1038/srep14790 ↗
25. 10.1002/admi.20220033910.1002/admi.202200339 ↗
26. 10.1002/anie.20210585610.1002/anie.202105856 ↗
27. 10.3390/ijms1907202110.3390/ijms19072021 ↗
28. 10.15671/hjbc.103591810.15671/hjbc.1035918 ↗
29. 10.1002/smll.20100183610.1002/smll.201001836 ↗
30. 10.1021/nl300044a10.1021/nl300044a ↗
31. 10.1016/j.mtbio.2022.10026310.1016/j.mtbio.2022.100263 ↗
32. 10.1111/nep.1200510.1111/nep.12005 ↗
33. 10.3389/fphar.2019.0165510.3389/fphar.2019.01655 ↗
34. 10.1080/20013078.2018.153575010.1080/20013078.2018.1535750 ↗
35. 10.1021/acs.langmuir.1c0311910.1021/acs.langmuir.1c03119 ↗
36. 10.3390/cells1012347310.3390/cells10123473 ↗
37. 10.1038/s41598-019-48181-610.1038/s41598-019-48181-6 ↗
38. 10.1016/j.ymeth.2015.03.02810.1016/j.ymeth.2015.03.028 ↗
39. 10.1002/smll.20200815510.1002/smll.202008155 ↗
40. 10.1007/978-1-4939-7253-110.1007/978-1-4939-7253-1 ↗
41. 10.1038/s41598-022-13101-810.1038/s41598-022-13101-8 ↗
42. 10.1016/j.biotechadv.2021.10781410.1016/j.biotechadv.2021.107814 ↗
43. 10.1016/j.bios.2016.08.00110.1016/j.bios.2016.08.001 ↗
44. 10.1038/s41598-019-38516-810.1038/s41598-019-38516-8 ↗
45. 10.1021/acsanm.4c0625210.1021/acsanm.4c06252 ↗
46. Zhou, X.Development of an ELISA assay for EV quantification to assist the large-scale EV manufacture. bioRxiv 2024.10.1101/2024.10.31.621446 ↗
47. 10.1186/s12934-017-0856-910.1186/s12934-017-0856-9 ↗
48. 10.3390/polym1311178110.3390/polym13111781 ↗
49. 10.1016/j.bios.2018.11.03010.1016/j.bios.2018.11.030 ↗
50. 10.3390/molecules2618561210.3390/molecules26185612 ↗
51. Ansell R. J. · 2015 · 5110.1007/10_2015_316 ↗
52. 10.1016/j.actbio.2011.03.00110.1016/j.actbio.2011.03.001 ↗
53. 10.1016/j.ijpharm.2022.12246310.1016/j.ijpharm.2022.122463 ↗
54. 10.3389/fchem.2017.0010210.3389/fchem.2017.00102 ↗
55. 10.1021/acs.nanolett.9b0496310.1021/acs.nanolett.9b04963 ↗
56. 10.1021/acsabm.4c0078210.1021/acsabm.4c00782 ↗
57. 10.1016/j.bios.2023.11542210.1016/j.bios.2023.115422 ↗
58. 10.1016/j.bios.2019.04.01310.1016/j.bios.2019.04.013 ↗
59. 10.1002/adom.20230167010.1002/adom.202301670 ↗
60. 10.1038/s41551-021-00752-710.1038/s41551-021-00752-7 ↗
61. 10.1021/acsnano.0c0279710.1021/acsnano.0c02797 ↗
62. 10.1039/c2lc20706k10.1039/c2lc20706k ↗
63. 10.2147/IJN.S2962910.2147/IJN.S29629 ↗
64. 10.2147/IJN.S3257910.2147/IJN.S32579 ↗
65. Ansys Lumerical FDTD Simulation for Photonic Components . https://www.ansys.com/products/optics/fdtd.
66. Palik E. D. · 1998 · 1